Proliferative Classification of Intracranially Injected HER2-positive Breast Cancer Cell Lines

HER2 is overexpressed in 25–30% of breast cancers, and approximately 30% of HER2-positive breast cancers metastasize to the brain. Although the incidence of brain metastasis in HER2-positive breast cancer is high, previous studies have been mainly based on cell lines of the triple-negative subtype,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuroiwa, Yuka, Nakayama, Jun, Adachi, Chihiro, Inoue, Takafumi, Watanabe, Shinya, Semba, Kentaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408688/
https://www.ncbi.nlm.nih.gov/pubmed/32640677
http://dx.doi.org/10.3390/cancers12071811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408688/
https://www.ncbi.nlm.nih.gov/pubmed/32640677
http://dx.doi.org/10.3390/cancers12071811

Ejemplares similares